Budget Amount *help |
¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
This study explored how health-promotion projects against infectious diseases deploy people and things, and how these deployments affect the actions of various actors such as community health nurses, community volunteers, and mothers of newborns. This research uncovered how although deliberately afforded deployments effectively coordinate these people’s actions regarding infant vaccination, there are nonetheless contradictions in the mass administration of ivermectin. At the same time, the study’s findings showed that it is not only the spatial deployment of pharmaceuticals that matters; the temporal dimension through documentation is also highly significant. Indeed, the rhythms of the administration of pharmaceuticals and vaccines depend on the skillful coordination of human bodies, pathogens, pharmaceuticals, and the everyday lives of people.
|